Results 201 to 210 of about 131,003 (284)

Traditional and Geometric Morphometrics and Invariant Shape Descriptors of Catfish Otoliths in the Yucatán Peninsula: Tools for Species Identification and Individual Size Estimation at Maya Archaeological Sites

Archaeometry, EarlyView.
ABSTRACT This study investigates the use of otolith shape analysis for species identification and size estimation in Ariopsis felis and Bagre marinus, based on 181 modern otoliths obtained from a scientific collection and recent sampling in the coastal regions of Campeche and Yucatán, as well as 39 archaeological otoliths corresponding to the Early ...
Ariana Solis‐Gómez, Jorge Luis Pérez‐Gonzalez, Nayeli Jiménez‐Cano, Maribel Badillo‐Alemán, Alfredo Gallardo‐Torres, Nidiyare Hevia‐Montiel, Daniel Arceo‐Carranza, Xavier Chiappa‐Carrara   +7 more
wiley   +1 more source

Assessment of the organizational factors in incident management practices in healthcare: A tree augmented Naive Bayes model. [PDF]

PLoS One
Albreiki S, Simsekler MCE, Qazi A, Bouabid A.   +3 more
europepmc   +1 more source

Predicting students' academic progress and related attributes in first-year medical students: an analysis with artificial neural networks and Naïve Bayes. [PDF]

BMC Med Educ
Monteverde-Suárez D, González-Flores P, Santos-Solórzano R, García-Minjares M, Zavala-Sierra I, de la Luz VL, Sánchez-Mendiola M.   +6 more
europepmc   +1 more source

To vary or not to vary: A flexible empirical Bayes factor for testing variance components

British Journal of Mathematical and Statistical Psychology, EarlyView.
Abstract Random effects are the gold standard for capturing structural heterogeneity, such as individual differences or temporal dependence. Yet testing their presence is difficult because variance components are constrained to be non‐negative, creating a boundary problem. This paper introduces a flexible empirical Bayes factor (EBF) for testing random
Fabio Vieira, Hongwei Zhao, Joris Mulder
wiley   +1 more source

Novel approaches for drug development against chronic primary pain: A systematic review

British Journal of Pharmacology, EarlyView.
Abstract Chronic primary pain (CPP) persisting for more than 3 months, associated with significant emotional distress without any known underlying cause, is an unmet medical need. Traditional or adjuvant analgesics do not provide satisfactory pain relief for a great proportion of these patients.
Valéria Tékus, Éva Borbély, Andreas Goebel, Ralf Baron, Zsófia Hajna, Zsuzsanna Helyes   +5 more
wiley   +1 more source

Cardiac surveillance in immune checkpoint inhibitor therapy: Insights from the Essen Cardio‐oncology Registry

British Journal of Pharmacology, EarlyView.
Abstract Background and Purpose Immune checkpoint inhibitors (ICI) have revolutionized cancer therapy, offering improvements in survival across various malignancies. However, their toxicities pose a major challenge for cardio‐oncology units. Despite their growing importance, data on effectiveness of such specialized units in mitigating ICI‐associated ...
Elias Haj‐Yehia, Lisa Zimmer, Lena Lampe, Dimitra Vlachopoulou, Matthias Totzeck, Tienush Rassaf, Raluca I. Mincu   +6 more
wiley   +1 more source

The Overlooked Autoantibody Repertoire: Exploring the Biomarker Potential of Downregulated Autoantibodies in NSCLC

Cancer Science, EarlyView.
This study identifies downregulated autoantibodies in NSCLC and demonstrates their diagnostic and prognostic utility. Integrating proteome‐wide screening and large‐cohort validation, we highlight a novel biomarker class that enhances early detection and patient stratification.
Yihao Liang, Hanke Ma, Wenke Sun, Ying Chen, Fengqi Chen, Yutong Li, Songyun Ouyang, Liping Dai   +7 more
wiley   +1 more source

Application of Internet of Things and Naive Bayes in Public Health Environmental Management of Government Institutions in China.

J Healthc Eng, 2021
Zhang Z, Zhang S.
europepmc   +1 more source

Comparison of Support Vector Machine, Naïve Bayes and Logistic Regression for Assessing the Necessity for Coronary Angiography. [PDF]

Int J Environ Res Public Health, 2020
Golpour P, Ghayour-Mobarhan M, Saki A, Esmaily H, Taghipour A, Tajfard M, Ghazizadeh H, Moohebati M, Ferns GA.   +8 more
europepmc   +1 more source

Twelve‐Month Real‐World Outcomes of Faricimab for Treatment‐Naive Neovascular AMD in Australia

Clinical &Experimental Ophthalmology, EarlyView.
ABSTRACT Background To provide insights into the effectiveness and safety of faricimab for treatment‐naïve eyes with neovascular age‐related macular degeneration (nAMD). Methods A retrospective cohort study using a prospectively‐designed registry. Treatment‐naïve eyes with nAMD in Australia starting treatment with faricimab between Jan 2023–Sep 2024 ...
Mark Gillies, Yohei Hashimoto, Rahman Nazari, Jennifer Arnold, Beibei Wang, Richard Barry, Ross Ferrier, Justin Game, Daniel Barthelmes   +8 more
wiley   +1 more source